Harald Blegen

2.6k citations

33 papers · 1.9k indexed · h-index 18

Impact in

Cancer Research top 2%
- Cancer Genomics and Diagnostics
Pathology and Forensic Medicine top 2%
- Genetic factors in colorectal cancer

Papers in

Cancer Research 10
- Cancer Genomics and Diagnostics 7
Oncology 16
- Cancer-related Molecular Pathways 10

Co-authors: Gert Auer Thomas Ried Evelin Schröck Kerstin Heselmeyer Stanislas du Manoir Rüdiger G. Steinbeck K. V. Shah Kerstin Heselmeyer‐Haddad
Journals: Genes Chromosomes and Cancer (5 papers)International Journal of Oncology (2 papers)Analytical Cellular Pathology (2 papers)International Journal of Gynecological Pathology (2 papers)British Journal of Cancer (1 paper)
Partner nations: Sweden United States Germany

In The Last Decade

Harald Blegen

33 papers receiving 1.9k citations

Peers

Countries citing papers authored by Harald Blegen

Since Specialization

Citations

This map shows the geographic impact of Harald Blegen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Blegen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Blegen more than expected).

Fields of papers citing papers by Harald Blegen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harald Blegen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Blegen. The network helps show where Harald Blegen may publish in the future.

Co-authors

The 25 scholars most cited alongside Harald Blegen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Harald Blegen Line = papers co-authored together Harald Blegen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pronounced chromosomal instability and multiple gene amplifications characterize ulcerative colitis–associated colorectal carcinomas Cancer Genetics and Cytogenetics ·Jens K. Habermann, Madhvi B. Upender, Uwe J. Roblick, Stefan Krüger, Sandra Freitag, Harald Blegen, Marc-Andre Kamel, H. Schimmelpenning, Gert Auer, Thomas Ried	2003	17
2	A Rat Model for Severe Limb Ischemia at Rest European Surgical Research ·Göran Lundberg, Clemente De Lucia, Harald Blegen, Bo Kalin, E. Wahlberg	2003	14
3	Vascular Growth Factor Expression in a Rat Model of Severe Limb Ischemia Journal of Surgical Research ·Clemente De Lucia, Antonio Komotar, Göran Lundberg, Harald Blegen, Eric Wahlberg	2002	38
4	DNA Amplifications and Aneuploidy, High Proliferative Activity and Impaired Cell Cycle Control Characterize Breast Carcinomas with Poor Prognosis Analytical Cellular Pathology ·Harald Blegen, Sigit Sapto Wibowo, Β. Michael Ghadimi, Juan L. Alegret, Anders Zetterberg, Gert Auer, Thomas Ried	2002	23
5	Genetic Instability Promotes the Acquisition of Chromosomal Imbalances in T1b and T1c Breast Adenocarcinomas Analytical Cellular Pathology ·Harald Blegen, Β. Michael Ghadimi, 张敏, Anders Zetterberg, Elina Eriksson, Gert Auer, Thomas Ried	2001	12
6	Frequent co-amplification of two different regions on 17q in aneuploid breast carcinomas Cancer Genetics and Cytogenetics ·A. Miyamoto, Anju Zhang, Ruth A. Horvath, Susanne Månér, Peter Zickert, Harald Blegen, Anders Zetterberg	2001	17
7	Prognostic significance of cell cycle proteins and genomic instability in borderline, early and advanced stage ovarian carcinomas International Journal of Gynecological Cancer ·Harald Blegen, N. Einhorn, K. Sjövall, Anna V. Roschke, B. Michael Ghadimi, Lisa M. McShane, Bo Nilsson, Sinda Ben Zekri, Thomas Ried, Gert Auer	2000	38
8	Recurrent Fallopian Tube Carcinoma: TP53 Mutation and Clinical Course International Journal of Gynecological Pathology ·B Medoff-Cooper, Harald Blegen, CEROID, А.А. Доможилова, Isabel de Lima Zanata, FW Ruscetti, Gert Auer	2000	3
9	TP53 mutations do not correlate with locoregional recurrence in stage I tongue carcinomas. PubMed ·Anders Högmo, Anne‐Lise Børresen‐Dale, Harald Blegen, Johan Lindholm, Richard Kuylenstierna, Gert Auer, Eva Munck‐Wikland	2000	8
10	Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: A phenotype/genotype correlation Genes Chromosomes and Cancer ·Thomas Ried, Kerstin Heselmeyer‐Haddad, Harald Blegen, Cristina-Elena Ciuntuc, Gert Auer	1999	231
11	Primary carcinoma of the fallopian tube: comparative genomic hybridization reveals high genetic instability and a specific, recurring pattern of chromosomal aberrations. PubMed ·Kerstin Heselmeyer, 刘逸夫, Harald Blegen, Evelin Schröck, Claes Silfverswärd, Keerti V. Shah, Gert Auer, Thomas Ried	1998	20
12	Primary Carcinoma of the Fallopian Tube International Journal of Gynecological Pathology ·Kerstin Heselmeyer, Ann‐Cathrin Hellström, Harald Blegen, Evelin Schröck, Claes Silfverswärd, Keerti V. Shah, Gert Auer, Thomas Ried	1998	16
13	Mevalonate-regulated mechanisms in cell growth control: role of dolichyl phosphate in expression of the insulin-like growth factor-1 receptor (IGF-1R) in comparison to Ras prenylation and expression of c-myc Glycobiology ·Anica Dricu, Min Wang, Magnus Hjertman, CEROID, Harald Blegen, Johan Wejde, Magdalena Carlberg, Olle Larsson	1997	52
14	A recurrent pattern of chromosomal aberrations and immunophenotypic appearance defines anal squamous cell carcinomas British Journal of Cancer ·Kerstin Heselmeyer, Stanislas du Manoir, Harald Blegen, Bertil Friberg, C. Svensson, Evelin Schröck, Timothy Veldman, K. V. Shah, Gert Auer, Thomas Ried	1997	40
15	Advanced‐stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q Genes Chromosomes and Cancer ·Kerstin Heselmeyer, Merryn Macville, Evelin Schröck, Harald Blegen, Ann‐Cathrin Hellström, Keerti V. Shah, Gert Auer, Thomas Ried	1997	7
16	Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors Genes Chromosomes and Cancer ·M Lubinska, Homayun Zojaji, Rüdiger G. Steinbeck, Harald Blegen, Evelin Schröck, Kerstin Heselmeyer, Stanislas du Manoir, Gert Auer	1996	326
17	Short exposures to tunicamycin induce apoptosis in SV40-transformed but not in normal human fibroblasts Carcinogenesis ·Magdalena Carlberg, Anica Dricu, Harald Blegen, George E.N. Kass, Sten Orrenius, Olle Larsson	1996	27
18	Mevalonic Acid Is Limiting for N-Linked Glycosylation and Translocation of the Insulin-like Growth Factor-1 Receptor to the Cell Surface Journal of Biological Chemistry ·Magdalena Carlberg, Anica Dricu, Harald Blegen, Min Wang, Magnus Hjertman, Peter Zickert, Anders Höög, Olle Larsson	1996	119
19	Utility of a proliferation marker in distinguishing between benign naevocellular naevi and naevocellular naevus-like lesions with malignant properties Melanoma Research ·Lena Kanter, Harald Blegen, Johan Wejde, Ana Cristina Almeida Alves, Olle Larsson	1995	21
20	A cell cycle study of human mammary epithelial cells. Cell Biology International ·Olle Larsson, Harald Blegen, Johan Wejde, Anders Zetterberg	1993	4

About Harald Blegen

Harald Blegen is a scholar working on Cancer Research, Oncology, Reproductive Medicine, Otorhinolaryngology and Gastroenterology, having authored 33 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (10 papers), Cancer Genomics and Diagnostics (7 papers), Genetic factors in colorectal cancer (6 papers), Genomic variations and chromosomal abnormalities (6 papers), Plant biochemistry and biosynthesis (5 papers), Gastrointestinal disorders and treatments (4 papers), Cervical Cancer and HPV Research (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). The work is most often cited by research in Cancer Research (755 citations), Pathology and Forensic Medicine (520 citations), Genetics (652 citations), Oncology (573 citations) and Molecular Biology (860 citations). Harald Blegen has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Gert Auer, Thomas Ried, Evelin Schröck, Kerstin Heselmeyer, Stanislas du Manoir, Rüdiger G. Steinbeck, K. V. Shah, Kerstin Heselmeyer‐Haddad, Olle Larsson and Keerti V. Shah. Their work appears in journals such as Genes Chromosomes and Cancer, International Journal of Oncology, Analytical Cellular Pathology, International Journal of Gynecological Pathology and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact